2003
DOI: 10.1161/01.cir.0000081166.87607.e2
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Potential of Phosphodiesterase 5 Inhibition for Cardiovascular Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

6
100
0
4

Year Published

2005
2005
2012
2012

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 144 publications
(110 citation statements)
references
References 73 publications
6
100
0
4
Order By: Relevance
“…Erectile dysfunction (ED) is a common medical condition linked both to endothelial dysfunction [1][2][3][4][5][6][7][8][9][10][11][12][13] as well as multiple other comorbid conditions. [14][15][16][17] Historically, the treatment for ED has been limited to a selected group of specialists, namely urologists and sexual therapists.…”
Section: Introductionmentioning
confidence: 99%
“…Erectile dysfunction (ED) is a common medical condition linked both to endothelial dysfunction [1][2][3][4][5][6][7][8][9][10][11][12][13] as well as multiple other comorbid conditions. [14][15][16][17] Historically, the treatment for ED has been limited to a selected group of specialists, namely urologists and sexual therapists.…”
Section: Introductionmentioning
confidence: 99%
“…Sildenafil is a phosphodiesterase (PDE) inhibitor with high selectivity against isoform 5 [9]. Phosphodiesterase-5 (PDE-5) is predominantly found in smooth muscle cells of the corpora cavernosa and in high concentrations in the pulmonary vasculature.…”
Section: Discussionmentioning
confidence: 99%
“…The phosphodiesterase enzymes catalyze the breakdown of cyclic nucleoside monophosphates. Isoform 5 is a cGMPspecific PDE [9]. Inhibition of PDE-5 results in an increased cellular level of cGMP, which increases vascular smooth muscle relaxation [1,9].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations